Category
Sepsis & Septic Shock
Journal
Lancet Respir Med
Takeaway
Polymyxin B haemoadsorption in EAA-selected endotoxic shock: 28d mortality 39% vs 45% (95.3% posterior probability).
Verdict
Positive
Year
2026
Lancet Respir Med
Polymyxin B haemoadsorption in EAA-selected endotoxic shock: 28d mortality 39% vs 45% (95.3% posterior probability).